Origin Therapeutics Holdings, Inc. (ROVA) Stock Price & Analysis

4 Followers

ROVA Stock Chart & Stats

CA$0.06CA$0.00(0.00%)

At close: Nov 11 4:00 PM EST

Day’s Range: CAD 0.06 - CAD 0.06
52-Week Range: CAD 0.03 - CAD 0.10
Previous Close: CAD 0.06
Volume: N/A
Average Volume (3M): 109.15K
Market Cap: CAD 11.30M
Enterprise Value: CAD 7.89M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): CAD 0
Price to Earnings (P/E): ―
Beta: -0.58
Next Earnings: Feb 03, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Origin Therapeutics Holdings, Inc. News

Altrova Health Makes First U.S. Sale of Needle-Free O-Spray Amid Growing Peptide Market

Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) has issued an announcement. Altrova Health has announced its first entry into the U.S. market with the sale of 2,000 units of its

3w agoROVA

Altrova Health Raises C$669,840 to Drive U.S. Distribution Push

An announcement from Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) is now available. Altrova Health has closed a non-brokered private placement, raising gross proceeds of C$669,840 through the issuance of

1M agoROVA

Altrova Health Cuts Debt With C$215,000 Share Settlement

Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) has issued an announcement. Altrova Health has completed a debt settlement transaction that converts C$215,000 of outstanding liabilities owed to three creditors into

1M agoROVA

Altrova Health Moves to Settle Consultant Debt Through Share Issuance

Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) just unveiled an announcement. Altrova Health Inc. plans to settle C$215,000 of debt owed to three consultants by issuing 3,583,333 common shares at

1M agoROVA

Altrova Health Secures Exclusive U.S. Distributor and Raises Capital for Market Launch

An announcement from Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) is now available. Altrova Health has signed an exclusive U.S. distribution agreement with Reliability Funding LLC, appointing it as the

2M agoROVA

Altrova Health Posts First Meaningful Commercial Revenue in Q3 Fiscal 2026

Origin Therapeutics Holdings, Inc. ( ($TSE:ROVA) ) just unveiled an announcement. Altrova Health reported its third-quarter fiscal 2026 results, highlighting its first meaningful commercial revenue as recent distribution and commercialization

2M agoROVA

ROVA FAQ

What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?

Origin Therapeutics Holdings, Inc. lowest stock price was C$0.03 and its highest was C$0.10 in the past 12 months.

What is Origin Therapeutics Holdings, Inc.’s market cap?

Origin Therapeutics Holdings, Inc.’s market cap is C$11.30M.

When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?

Origin Therapeutics Holdings, Inc. released its earnings results on Aug 31, 2026. The company reported -C$0.006 earnings per share for the quarter.

Is Origin Therapeutics Holdings, Inc. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Origin Therapeutics Holdings, Inc. pay dividends?

Origin Therapeutics Holdings, Inc. does not currently pay dividends.

What is Origin Therapeutics Holdings, Inc.’s EPS estimate?

Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Origin Therapeutics Holdings, Inc. have?

Origin Therapeutics Holdings, Inc. has 205,374,530 shares outstanding.

What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?

Origin Therapeutics Holdings, Inc. reported an EPS of -C$0.006 in its last earnings report. Following the earnings report the stock price went up 9.091%.

Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?

Currently, no hedge funds are holding shares in TSE:ROVA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description